SecBot SecBot
Insider Buy ·Filed Jul 14, 2026

ARTV

Artiva Biotherapeutics, Inc.
BULLISH
Impact 5/10
Horizonweeks Processed4mo ago SEC0001231919-26-000764
Insider cluster: 1 insiders, $135K total
Actionable Insight ▲ Bullish

The purchase by a 10% owner is a positive signal, but the dollar amount is small relative to market cap. Monitor for additional insider buying or company catalysts (e.g., pipeline updates, partnerships) that could drive further conviction.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$9.92
T+0 close · Jul 14, 2026 · via day close
Latest settled
−31.45%
T+60 · $6.80
Vs SPY
−33.98%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 15 $9.92entry
  2. T+1 · 4mo ago −8.87%α −8.33% · $9.04
  3. T+5 · 4mo ago +1.01%α +1.99% · $10.02
  4. T+20 · 3mo ago +16.23%α +13.89% · $11.53
  5. T+60 · 6w ago −31.45%α −33.98% · $6.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RA Capital Management, L.P., a director and 10% owner of Artiva Biotherapeutics, purchased 15,100 shares at $8.97 for a total of $135K on July 10, 2026. This is a standalone conviction buy by a major insider, signaling confidence in the company's prospects at current valuation.

Key Financial Metrics

Direction
buying
Total Value
$135.0K
Insiders
1

Key Facts

  • RA Capital Management (Director, 10% Owner) bought 15,100 shares at $8.97 for $135K on July 10, 2026.
  • Total purchase value of $135K represents approximately 0.06% of Artiva's $221M market cap.
  • Recent insider activity shows 6 buys totaling $1.7M in the last 30 days, indicating sustained insider confidence.
  • Analyst consensus is 92% bullish (4 Strong Buy, 7 Buy, 1 Hold).

Financial Impact

Insider purchase of $135K, representing 0.06% of market cap.

insider ownership

Risk Factors

  • The purchase amount ($135K) is small relative to market cap (0.06%), limiting its signaling power.
  • Biotech sector volatility and binary pipeline events could overshadow insider buying.
  • RA Capital may be averaging into a position rather than signaling a near-term catalyst.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001231919-26-000764

Track record

33 reports on ARTV

Performance horizon

10 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
  2. Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
  3. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
  4. Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
  5. Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
  6. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  7. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  10. Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
Showing 10 of 33

US Market Status

Market Closed · Opens in 5h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 14, 2026